Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 542138

Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.


Jelisavac-Čosić, Sanda; Sirotković-Skerlev, Maja; Kulić, Ana; Jakić-Razumović, Jasna; Kovač, Zdenko; Vrbanec, Damir
Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study. // Tumori, 97 (2011), 4; 532-539 doi:10.1700/950.10409 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 542138 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.

Autori
Jelisavac-Čosić, Sanda ; Sirotković-Skerlev, Maja ; Kulić, Ana ; Jakić-Razumović, Jasna ; Kovač, Zdenko ; Vrbanec, Damir

Izvornik
Tumori (0300-8916) 97 (2011), 4; 532-539

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
uPA ; PAI-1 ; breast cancer

Sažetak
Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) are key molecules in pericellular proteolysis, a process that plays an important role in tumor invasion and metastasis. In the current study we investigated the prognostic significance of uPA and PAI-1 in primary invasive breast cancer. uPA and PAI-1 antigen levels were determined by enzyme-linked immunosorbent assay in cytosols of 177 invasive ductal carcinoma specimens. The prognostic significance of uPA and PAI-1 was assessed for overall survival. The median follow-up time was 90 months. In univariate analysis, both uPA (third versus first tertile range of values ; P = 0.02 ; HR = 2.08) and PAI-1 (third versus first tertile ; P = 0.0007 ; HR = 3.1) were significant prognostic markers for overall survival. In multivariate analysis only nodal status (N2 vs N0 ; P = 0.0001 ; HR = 3.94) and PAI-1 (third versus first tertile ; P = 0.004 ; HR = 3.05) remained significant independent prognostic factors. Both uPA and PAI-1 were correlated with established prognostic markers including histological grade, tumor size and Nottingham index. Our study with a 7.5-year follow-up confirmed the relation between elevated uPA and PAI-1 values and an aggressive course of invasive breast cancer. The prognostic significance of PAI-1 as an independent marker was proved for the overall group of breast cancer patients and the subgroup of node-positive patients.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
098-0982464-2508 - Molekularna genetika i farmakogenetika gastrointestinalnih tumora (Kapitanović, Sanja, MZOS ) ( CroRIS)
108-0000000-2063 - Patofiziologija sepse u splenektomiranim i normospleničnim miševima (Kovačić, Zdenko, MZOS ) ( CroRIS)
108-1080058-0046 - KARCINOM DOJKE-MOLEKULARNE,GENETSKE I KLINIČKE KARAKTERISTIKE (Vrbanec, Damir, MZOS ) ( CroRIS)
108-1080058-0047 - Molekularni biljezi u solidnim tumorima - prediktivni i prognostički značaj (Pleština, Stjepko, MZOS ) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb

Profili:

Avatar Url Ana Kulić (autor)

Avatar Url Maja Sirotković-Skerlev (autor)

Avatar Url Damir Vrbanec (autor)

Poveznice na cjeloviti tekst rada:

doi www.tumorionline.it

Citiraj ovu publikaciju:

Jelisavac-Čosić, Sanda; Sirotković-Skerlev, Maja; Kulić, Ana; Jakić-Razumović, Jasna; Kovač, Zdenko; Vrbanec, Damir
Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study. // Tumori, 97 (2011), 4; 532-539 doi:10.1700/950.10409 (međunarodna recenzija, članak, znanstveni)
Jelisavac-Čosić, S., Sirotković-Skerlev, M., Kulić, A., Jakić-Razumović, J., Kovač, Z. & Vrbanec, D. (2011) Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.. Tumori, 97 (4), 532-539 doi:10.1700/950.10409.
@article{article, author = {Jelisavac-\v{C}osi\'{c}, Sanda and Sirotkovi\'{c}-Skerlev, Maja and Kuli\'{c}, Ana and Jaki\'{c}-Razumovi\'{c}, Jasna and Kova\v{c}, Zdenko and Vrbanec, Damir}, year = {2011}, pages = {532-539}, DOI = {10.1700/950.10409}, keywords = {uPA, PAI-1, breast cancer}, journal = {Tumori}, doi = {10.1700/950.10409}, volume = {97}, number = {4}, issn = {0300-8916}, title = {Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.}, keyword = {uPA, PAI-1, breast cancer} }
@article{article, author = {Jelisavac-\v{C}osi\'{c}, Sanda and Sirotkovi\'{c}-Skerlev, Maja and Kuli\'{c}, Ana and Jaki\'{c}-Razumovi\'{c}, Jasna and Kova\v{c}, Zdenko and Vrbanec, Damir}, year = {2011}, pages = {532-539}, DOI = {10.1700/950.10409}, keywords = {uPA, PAI-1, breast cancer}, journal = {Tumori}, doi = {10.1700/950.10409}, volume = {97}, number = {4}, issn = {0300-8916}, title = {Prognostic significance of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor (PAI-1) in patients with primary invasive ductal breast carcinoma - a 7.5-year follow-up study.}, keyword = {uPA, PAI-1, breast cancer} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font